Berapa harga Psyence Biomedical Ltd. (PBM)

Harga Psyence Biomedical Ltd. (PBM) adalah $3.20

Apa kapitalisasi pasar Psyence Biomedical Ltd. (PBM)

Kapitalisasi pasar Psyence Biomedical Ltd. (PBM) adalah $60.86K

Psyence Biomedical Ltd. (PBM) Saham Beredar

Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study. This product is being developed to treat anxiety, depression, and associated conditions such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010, utilizing psilocybin-assisted psychotherapy for adjustment disorder arising from incurable cancer. Additionally, the company holds a strategic alliance with PsyLabs for the manufacturing of Ibogaine. Headquartered in Toronto, Canada, Psyence Biomedical Ltd. functions as a subsidiary of Psyence Group Inc.

Tahun	Saham Beredar	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Saham Beredar

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Saham Beredar	Perbedaan	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	0.00	-	BE

Perusahaan

Saham Beredar

Perbedaan

Negara